AWAayush Wellness539528Quarterly results

Board approves Q2 & H1 FY27 results; consolidated Total income ₹7,061.82 lakhs, up 10.61%

Board approved the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026.

By ScoutQuest · Tue 3 Nov 2026, 5:51 PM IST · 2 min read

H1 FY27 Consolidated Total Income

₹7,061.82 lakhs, up 10.61%

H1 FY27 Consolidated PAT

₹250.10 lakhs, up 5.86%

Q2 FY27 Consolidated Total Income

₹3,685.67 lakhs, up 9.17% sequentially

What was approved

The board approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The numbers below are for the half year and quarter reported in the update.

Consolidated performance

• Total income for H1 FY27 was ₹7,061.82 lakhs, against ₹6,384.84 lakhs in H1 FY26, a growth of 10.61% year on year.
• Profit After Tax for H1 FY27 was ₹250.10 lakhs, against ₹236.26 lakhs in H1 FY26, up 5.86% year on year.
• For Q2 FY27, consolidated Total income was ₹3,685.67 lakhs, a sequential rise of 9.17% from ₹3,376.15 lakhs in Q1 FY27.
• Q2 FY27 consolidated Profit After Tax was ₹108.48 lakhs.

Standalone performance

• Q2 FY27 standalone total income was ₹2,639.31 lakhs, up 6.77% from ₹2,471.91 lakhs in Q1 FY27.
• Q2 FY27 standalone Profit Before Tax was ₹135.01 lakhs, against ₹119.93 lakhs in the previous quarter, a rise of 12.57%.
• H1 FY27 standalone total income was ₹5,111.22 lakhs, and standalone Profit Before Tax was ₹254.96 lakhs, against ₹237.03 lakhs in H1 FY26, up 7.56%.
• Standalone basic and diluted earnings per share were ₹0.28 for Q2 FY27 and ₹0.52 for H1 FY27, on shares of face value Re. 1 each.

Auditor's review conclusion

A. Raghavendra Rao & Associates, Chartered Accountants, carried out a limited review of the standalone quarterly statements. Their conclusion states that nothing came to their attention that causes them to believe the statements are not prepared, in all material respects, in accordance with applicable accounting standards and recognised accounting practices. The report also notes that a review is substantially less in scope than an audit and that no audit opinion is expressed.

Balance sheet position (standalone)

• Total assets stood at ₹1,913.52 lakhs as at September 30, 2026, against ₹1,685.03 lakhs as at March 31, 2026.
• Total equity was ₹1,484.96 lakhs, against ₹1,230.01 lakhs at the previous year end.
• Non-current borrowings were ₹404.53 lakhs, unchanged from March 31, 2026.
• Total liabilities were ₹428.56 lakhs, against ₹455.02 lakhs.

Product portfolio

The update notes expansion of the wellness range: Aayush Calcium Vitamin Tablets for the bone and joint health segment, launched on October 16, 2026, following Lung Care Tablets in August 2026 and Dia Shield Tablets in May 2026. The stated focus is a wider preventive healthcare and nutraceutical portfolio.

Management comment

Mr. Lalitkumar Anande, Director, described the H1 FY27 performance as reflecting progress in consolidated operations, with the stated focus on strengthening business fundamentals, operational efficiency, cost optimisation and profitability, alongside revenue growth.

What a reader can take away

• Both income and profit grew year on year at the consolidated level, with profit growth (5.86%) slower than income growth (10.61%).
• The quarter was ahead of the previous quarter on both income and profit at the consolidated level.
• The auditor's review conclusion carries no qualification or adverse remark.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev